News
-
-
PRESS RELEASE
Informations privilégiées / Autres communiqués
ABIONYX Pharma rapporte un chiffre d'affaires consolidé de 0,8 M€ au T1 2026 et la stabilité de sa trésorerie à 2,8 M€. Perspective financière repoussée à fin 2028 avec renforcement des ressources par une augmentation de capital sécurisée à 100% -
-
-
-
-
PRESS RELEASE
Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Menarini Group presents new data from Phase 1b/2 ELEVATE Study of Elacestrant in combination with Capivasertib for ER+, HER2- Metastatic Breast Cancer at ASCO Annual Meeting 2026 -
PRESS RELEASE
Following Sanctions-Risk Information from Western Partners, the Ministry of Justice of the Kyrgyz Republic Suspends 50 Legal Entities in First-Ever Use of Interagency Law to Crack Down on Malign Foreign Economic Activity
The Ministry of Justice of the Kyrgyz Republic suspends 50 legal entities after sanctions-risk information from Western partners, cracking down on malign foreign economic activity -
-
